These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28918671)

  • 1. Long term outcomes of severe combined immunodeficiency: therapy implications.
    Heimall J; Cowan MJ
    Expert Rev Clin Immunol; 2017 Nov; 13(11):1029-1040. PubMed ID: 28918671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
    Thakar MS; Logan BR; Puck JM; Dunn EA; Buckley RH; Cowan MJ; O'Reilly RJ; Kapoor N; Satter LF; Pai SY; Heimall J; Chandra S; Ebens CL; Chellapandian D; Williams O; Burroughs LM; Saldana BD; Rayes A; Madden LM; Chandrakasan S; Bednarski JJ; DeSantes KB; Cuvelier GDE; Teira P; Gillio AP; Eissa H; Knutsen AP; Goldman FD; Aquino VM; Shereck EB; Moore TB; Caywood EH; Lugt MTV; Rozmus J; Broglie L; Yu LC; Shah AJ; Andolina JR; Liu X; Parrott RE; Dara J; Prockop S; Martinez CA; Kapadia M; Jyonouchi SC; Sullivan KE; Bleesing JJ; Chaudhury S; Petrovic A; Keller MD; Quigg TC; Parikh S; Shenoy S; Seroogy C; Rubin T; Decaluwe H; Routes JM; Torgerson TR; Leiding JW; Pulsipher MA; Kohn DB; Griffith LM; Haddad E; Dvorak CC; Notarangelo LD
    Lancet; 2023 Jul; 402(10396):129-140. PubMed ID: 37352885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: need for safer conditioning and reduced late effects.
    Horn B; Cowan MJ
    J Allergy Clin Immunol; 2013 May; 131(5):1306-11. PubMed ID: 23622119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.
    Heimall J; Logan BR; Cowan MJ; Notarangelo LD; Griffith LM; Puck JM; Kohn DB; Pulsipher MA; Parikh S; Martinez C; Kapoor N; O'Reilly R; Boyer M; Pai SY; Goldman F; Burroughs L; Chandra S; Kletzel M; Thakar M; Connelly J; Cuvelier G; Davila Saldana BJ; Shereck E; Knutsen A; Sullivan KE; DeSantes K; Gillio A; Haddad E; Petrovic A; Quigg T; Smith AR; Stenger E; Yin Z; Shearer WT; Fleisher T; Buckley RH; Dvorak CC
    Blood; 2017 Dec; 130(25):2718-2727. PubMed ID: 29021228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten Years of Newborn Screening for Severe Combined Immunodeficiency (SCID) in Massachusetts.
    Hale JE; Platt CD; Bonilla FA; Hay BN; Sullivan JL; Johnston AM; Pasternack MS; Hesterberg PE; Meissner HC; Cooper ER; Barmettler S; Farmer JR; Fisher D; Walter JE; Yang NJ; Sahai I; Eaton RB; DeMaria A; Notarangelo LD; Pai SY; Comeau AM
    J Allergy Clin Immunol Pract; 2021 May; 9(5):2060-2067.e2. PubMed ID: 33607339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.
    Haddad E; Logan BR; Griffith LM; Buckley RH; Parrott RE; Prockop SE; Small TN; Chaisson J; Dvorak CC; Murnane M; Kapoor N; Abdel-Azim H; Hanson IC; Martinez C; Bleesing JJH; Chandra S; Smith AR; Cavanaugh ME; Jyonouchi S; Sullivan KE; Burroughs L; Skoda-Smith S; Haight AE; Tumlin AG; Quigg TC; Taylor C; Dávila Saldaña BJ; Keller MD; Seroogy CM; Desantes KB; Petrovic A; Leiding JW; Shyr DC; Decaluwe H; Teira P; Gillio AP; Knutsen AP; Moore TB; Kletzel M; Craddock JA; Aquino V; Davis JH; Yu LC; Cuvelier GDE; Bednarski JJ; Goldman FD; Kang EM; Shereck E; Porteus MH; Connelly JA; Fleisher TA; Malech HL; Shearer WT; Szabolcs P; Thakar MS; Vander Lugt MT; Heimall J; Yin Z; Pulsipher MA; Pai SY; Kohn DB; Puck JM; Cowan MJ; O'Reilly RJ; Notarangelo LD
    Blood; 2018 Oct; 132(17):1737-1749. PubMed ID: 30154114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API).
    Speckmann C; Nennstiel U; Hönig M; Albert MH; Ghosh S; Schuetz C; Brockow I; Hörster F; Niehues T; Ehl S; Wahn V; Borte S; Lehmberg K; Baumann U; Beier R; Krüger R; Bakhtiar S; Kuehl JS; Klemann C; Kontny U; Holzer U; Meinhardt A; Morbach H; Naumann-Bartsch N; Rothoeft T; Kreins AY; Davies EG; Schneider DT; Bernuth HV; Klingebiel T; Hoffmann GF; Schulz A; Hauck F
    J Clin Immunol; 2023 Jul; 43(5):965-978. PubMed ID: 36843153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
    Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
    J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal Newborn Screening Follow-up for Severe Combined Immunodeficiency in an Amish Cohort with Cartilage-Hair Hypoplasia.
    Scott EM; Chandra S; Li J; Robinette ED; Brown MF; Wenger OK
    J Clin Immunol; 2020 Feb; 40(2):321-328. PubMed ID: 31903518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined Immunodeficiency.
    Ozturk E; Catak MC; Kiykim A; Baser D; Bilgic Eltan S; Yalcin K; Kasap N; Nain E; Bulutoglu A; Akgun G; Can Y; Sefer AP; Babayeva R; Caki-Kilic S; Tezcan Karasu G; Yesilipek A; Ozen A; Karakoc-Aydiner E; Baris S
    J Clin Immunol; 2022 Jul; 42(5):1036-1050. PubMed ID: 35451701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival After Hematopoietic Stem Cell Transplantation in Severe Combined Immunodeficiency (SCID): A Worldwide Review of the Prognostic Variables.
    Goebel GA; de Assis CS; Cunha LAO; Minafra FG; Pinto JA
    Clin Rev Allergy Immunol; 2024 Apr; 66(2):192-209. PubMed ID: 38689103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases.
    Cowan MJ; Neven B; Cavazanna-Calvo M; Fischer A; Puck J
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):73-5. PubMed ID: 18162224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
    Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W
    J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The case for mandatory newborn screening for severe combined immunodeficiency (SCID).
    Gaspar HB; Hammarström L; Mahlaoui N; Borte M; Borte S
    J Clin Immunol; 2014 May; 34(4):393-7. PubMed ID: 24691999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC II deficient infant identified by newborn screening program for SCID.
    Marcus N; Stauber T; Lev A; Simon AJ; Stein J; Broides A; Somekh I; Almashanu S; Somech R
    Immunol Res; 2018 Aug; 66(4):537-542. PubMed ID: 30084052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.
    Hassan A; Booth C; Brightwell A; Allwood Z; Veys P; Rao K; Hönig M; Friedrich W; Gennery A; Slatter M; Bredius R; Finocchi A; Cancrini C; Aiuti A; Porta F; Lanfranchi A; Ridella M; Steward C; Filipovich A; Marsh R; Bordon V; Al-Muhsen S; Al-Mousa H; Alsum Z; Al-Dhekri H; Al Ghonaium A; Speckmann C; Fischer A; Mahlaoui N; Nichols KE; Grunebaum E; Al Zahrani D; Roifman CM; Boelens J; Davies EG; Cavazzana-Calvo M; Notarangelo L; Gaspar HB;
    Blood; 2012 Oct; 120(17):3615-24; quiz 3626. PubMed ID: 22791287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening.
    de Pagter AP; Bredius RG; Kuijpers TW; Tramper J; van der Burg M; van Montfrans J; Driessen GJ;
    Eur J Pediatr; 2015 Sep; 174(9):1183-8. PubMed ID: 25875249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How I treat severe combined immunodeficiency.
    Gaspar HB; Qasim W; Davies EG; Rao K; Amrolia PJ; Veys P
    Blood; 2013 Nov; 122(23):3749-58. PubMed ID: 24113871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Heimall J; Buckley RH; Puck J; Fleisher TA; Gennery AR; Haddad E; Neven B; Slatter M; Roderick S; Baker KS; Dietz AC; Duncan C; Griffith LM; Notarangelo L; Pulsipher MA; Cowan MJ
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1229-1240. PubMed ID: 28479164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.